In light of the COVID-19 outbreak, recruitment to Baby-OSCAR was paused on 18th March 2020. Recruitment has now re-started in a small number of sites. If you have any queries please contact the Trial Team directly.
This research is about babies who have been born early (prematurely).
The aim of this study is to find out whether or not a confirmed large Patent Ductus Arteriosus (PDA) in very premature babies should be treated with ibuprofen within 72 hours of birth.
The study title is: Outcome after Selective Early Treatment for Closure of Patent Ductus ARteriosus in Pre-term Babies, or Baby-OSCAR in short.
Co-ordination, Sponsorship and Funding
This multi-centre trial is co-ordinated from the National Perinatal Epidemiology Unit Clinical Trial unit (NPEU CTU) at the University of Oxford and is sponsored by the University of Oxford. Funding is provided by the National Institute of Health Research (NIHR) Health Technology Assessment (HTA) programme (project reference 11/92/15). The ISRCTN is: 84264977.